Several studies report the protective effects of TREM2 on survival rates, organ damage, and inflammatory responses in metabolic dysfunction–associated steatotic liver disease–induced (MASLD-induced) (32) or CLP sepsis mouse models (70, 71). Here, TREM2 is linked to metabolic dysfunction-associated steatotic liver disease.